Home
>
National Drug Code (NDC)
>
ARIXTRA
ARIXTRA - 0007-3230-02 - (fondaparinux sodium)
Drug Information of ARIXTRA
| Product NDC: | 0007-3230 |
| Proprietary Name: | ARIXTRA |
| Non Proprietary Name: | fondaparinux sodium |
| Active Ingredient(s): | 2.5 mg/.5mL & nbsp; fondaparinux sodium |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ARIXTRA
| Product NDC: | 0007-3230 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021345 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050330 |
Package Information of ARIXTRA
| Package NDC: | 0007-3230-02 |
| Package Description: | 2 SYRINGE in 1 CARTON (0007-3230-02) > .5 mL in 1 SYRINGE (0007-3230-01) |
NDC Information of ARIXTRA
| NDC Code | 0007-3230-02 |
| Proprietary Name | ARIXTRA |
| Package Description | 2 SYRINGE in 1 CARTON (0007-3230-02) > .5 mL in 1 SYRINGE (0007-3230-01) |
| Product NDC | 0007-3230 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fondaparinux sodium |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20050330 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | FONDAPARINUX SODIUM |
| Strength Number | 2.5 |
| Strength Unit | mg/.5mL |
| Pharmaceutical Classes | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] |
